Stifel Financial Corp Has Upped Merck & Co INC (MRK) Position by $7.46 Million

November 14, 2017 - By Vivian Park

Investors sentiment increased to 1.07 in 2017 Q2. Its up 0.08, from 0.99 in 2017Q1. It is positive, as 56 investors sold MRK shares while 612 reduced holdings. 111 funds opened positions while 603 raised stakes. 1.95 billion shares or 0.77% less from 1.96 billion shares in 2017Q1 were reported. Columbia Asset Mngmt has 155,743 shares. 8,786 were accumulated by Sns Fincl Grp Inc Ltd Liability. Foyston Gordon Payne holds 79,299 shares. Opus Point Ptnrs Ltd Liability Corp owns 83,700 shares for 4.94% of their portfolio. Brandywine Investment Ltd Company holds 2.48 million shares. Kames Public Ltd Com accumulated 893,596 shares. Numeric Invsts Ltd Com reported 422,556 shares or 0.24% of all its holdings. Moreover, Chickasaw Capital Management Ltd Liability has 0.05% invested in Merck & Co., Inc. (NYSE:MRK). The Illinois-based Ativo Capital Limited has invested 0.36% in Merck & Co., Inc. (NYSE:MRK). Campbell Newman Asset Mngmt stated it has 28,665 shares or 0.33% of all its holdings. Macquarie has invested 1.44% of its portfolio in Merck & Co., Inc. (NYSE:MRK). 27,229 are held by Hanson And Doremus Inv. The Illinois-based Graybill Bartz & Assoc has invested 3.17% in Merck & Co., Inc. (NYSE:MRK). X Mgmt Co Ltd Liability reported 8,702 shares or 0.02% of all its holdings. Westpac Bk Corporation invested 0% in Merck & Co., Inc. (NYSE:MRK).

Stifel Financial Corp increased its stake in Merck & Co Inc (MRK) by 3.65% based on its latest 2017Q2 regulatory filing with the SEC. Stifel Financial Corp bought 116,491 shares as the company’s stock declined 2.46% while stock markets rallied. The institutional investor held 3.31 million shares of the health care company at the end of 2017Q2, valued at $211.98 million, up from 3.19 million at the end of the previous reported quarter. Stifel Financial Corp who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $149.87B market cap company. The stock declined 0.27% or $0.15 reaching $54.95 on the news. About 2.32 million shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since November 14, 2016 and is uptrending. It has outperformed by 0.16% the S&P500.

Stifel Financial Corp, which manages about $26.93B US Long portfolio, decreased its stake in Metlife Inc (NYSE:MET) by 58,611 shares to 967,425 shares, valued at $53.01M in 2017Q2, according to the filing. It also reduced its holding in Cdw Corp (NASDAQ:CDW) by 129,258 shares in the quarter, leaving it with 145,055 shares, and cut its stake in Grainger W W Inc (NYSE:GWW).

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: which released: “Merck & Co., Inc. (MRK) Takes a Hit After Q3 Loss” on October 27, 2017, also with their article: “Merck & Co. Inc.: Merck Announces Final Results of Any and All Tender Offers” published on November 14, 2017, published: “Merck’s Risk/Reward Is Compelling” on October 16, 2017. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: and their article: “Here’s Why Merck & Co., Inc. Tanked 14% in October” published on November 08, 2017 as well as‘s news article titled: “Merck Pulls The Plug On Cholesterol Drug” with publication date: October 16, 2017.

Merck & Co., Inc. (NYSE:MRK) Ratings Coverage

Among 22 analysts covering Merck & Co. Inc. (NYSE:MRK), 14 have Buy rating, 0 Sell and 8 Hold. Therefore 64% are positive. Merck & Co. Inc. has $7400 highest and $50 lowest target. $66.59’s average target is 21.18% above currents $54.95 stock price. Merck & Co. Inc. had 67 analyst reports since August 13, 2015 according to SRatingsIntel. On Tuesday, July 4 the stock rating was maintained by BMO Capital Markets with “Sell”. On Thursday, August 13 the stock rating was upgraded by BMO Capital Markets to “Outperform”. The firm has “Market Perform” rating by Cowen & Co given on Wednesday, April 12. The firm has “Hold” rating given on Friday, April 15 by Jefferies. The firm has “Buy” rating by SunTrust given on Friday, July 28. On Monday, October 30 the stock rating was downgraded by SunTrust to “Hold”. The rating was initiated by Berenberg with “Buy” on Tuesday, November 24. Barclays Capital maintained the stock with “Overweight” rating in Friday, September 9 report. Bank of America upgraded the shares of MRK in report on Thursday, October 13 to “Buy” rating. The stock of Merck & Co., Inc. (NYSE:MRK) has “Hold” rating given on Tuesday, June 14 by Jefferies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.